ALNYLAM PHARMACEUTICALS, INC. Quarterly Operating Lease, Payments in USD from Q1 2019 to Q1 2022

Taxonomy & unit
us-gaap: USD
Description
Amount of cash outflow from operating lease, excluding payments to bring another asset to condition and location necessary for its intended use.
Summary
Alnylam Pharmaceuticals, Inc. annual/quarterly Operating Lease, Payments history and growth rate from Q1 2019 to Q1 2022.
  • Alnylam Pharmaceuticals, Inc. Operating Lease, Payments for the quarter ending March 31, 2022 was $10.7M, a 17.8% increase year-over-year.
  • Alnylam Pharmaceuticals, Inc. annual Operating Lease, Payments for 2023 was $46.5M, a 7.89% increase from 2022.
  • Alnylam Pharmaceuticals, Inc. annual Operating Lease, Payments for 2022 was $43.1M, a 2.86% increase from 2021.
  • Alnylam Pharmaceuticals, Inc. annual Operating Lease, Payments for 2021 was $41.9M, a 10.3% increase from 2020.
Operating Lease, Payments, Quarterly (USD)
Operating Lease, Payments, YoY Quarterly Growth (%)
Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed
Q1 2022 $10.7M +$1.61M +17.8% Jan 1, 2022 Mar 31, 2022 10-Q 2022-04-28
Q1 2021 $9.06M +$24K +0.27% Jan 1, 2021 Mar 31, 2021 10-Q 2022-04-28
Q1 2020 $9.04M +$1.33M +17.3% Jan 1, 2020 Mar 31, 2020 10-Q 2021-04-29
Q1 2019 $7.7M Jan 1, 2019 Mar 31, 2019 10-Q 2020-05-06
* An asterisk sign (*) next to the value indicates that the value is likely invalid.